Steigerwald, Gordon & Koch Inc. Eli Lilly & CO Transaction History
Steigerwald, Gordon & Koch Inc.
- $932 Million
- Q2 2025
A detailed history of Steigerwald, Gordon & Koch Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Steigerwald, Gordon & Koch Inc. holds 2,948 shares of LLY stock, worth $2.4 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
2,948
Previous 3,093
4.69%
Holding current value
$2.4 Million
Previous $2.55 Million
10.02%
% of portfolio
0.25%
Previous 0.29%
Shares
26 transactions
Others Institutions Holding LLY
# of Institutions
4,399Shares Held
807MCall Options Held
10MPut Options Held
10.8M-
Pnc Financial Services Group, Inc. Pittsburgh, PA101MShares$82.3 Billion44.13% of portfolio
-
Lilly Endowment Inc Indianapolis, IN96MShares$78 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA79.2MShares$64.4 Billion1.22% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$53.5 Billion1.37% of portfolio
-
State Street Corp Boston, MA34.4MShares$28 Billion1.2% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $772B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...